生物中國抗體仿制藥國際峰會2012將于6月在上海召開
生物中國抗體仿制藥國際峰會2012
2012年6月26-27日 中國.上海
BioChina International 2012
--- Capitalize on R&D and Bioprocessing Capabilities of
China’s Biopharma Industry and International Partnership
Date: June 26th - 27th, 2012
Location: Shanghai, China
Website: http://bci2012.
On the way to achieve antibody industrialization, China is faced with challenges in transforming good research into effective products that can be reproduced in large quantities and meet all regulatory and quality standards. The key to overcome above challenges lies in bioprocess. Advancements on scale-up, pilot production, purification, expression technologies, quality control etc are some key issues that the industry stakeholders need to take into consideration when working on strategies to bring China’s biopharma industry into the next level . Apart from challenges in bioprocess technologies, China is working toward to better biosimilar and antibody R&D to fill limited product pipelines. With patent cliff for most of biologics in 2015, biosimilar has been recognized as great opportunities and major trends for future biopharma’s industry.
Riding on the booming biopharma industry in China, the inaugural BioChina International Conference 2012 is positioned to be the largest biopharma conference in China to focus on latest bioprocess and antibody advancement in China and globally. The content rich conference aims to build a definitive platform for biopharma industry leaders to gain proven strategies and solutions to finding new targets, optimizing epitope design for monoclonal antibody, scaling up both upstream and downstream processes, building pilot plant, advancing cell line development, improving quality and ensuring comparability of mAbs, biosimilars, biobetters and vaccines.
For more information, please contact Daniel Chen at 8621-32516046 or email daniel.chen@ for more information. Event website: http://bci2012./
- 因美納邀您參加CSCO第九屆血液腫瘤學術大會
- 千奧星科精彩亮相2025神經科學技術研討會
- 諾達思攜多款產品亮相2025中國人類工效學學術會議
- 美森與您相約CMC-CHINA第七屆中國制藥工業博覽會
- CPHI&PMEC 2025制藥工業展（深圳）通知
- 2026第三十三屆成都醫療健康博覽會邀請函
- NGDx2025中國先進診斷技術開發與應用論壇議程表
- 關于征集藥食同源及藥膳配方食品標準試點單位的通知
- 關于征集藥食同源優選產品評價規范參編單位的通知
- QD中國攜單細胞方案亮相國際干細胞研究學會年會
- 維拓啟創助力2025表面肌電論壇在杭成功召開
- 易科泰應邀參加動物遺傳專業委員會2025年學術年會
- 奧偉登攜前沿顯微技術亮相廈門2025中國材料大會
- CIIDC 2025中國（成都）儀器創新發展大會通知
- 2025新疆（昌吉）農業展覽會即將震撼啟幕
- 杭州費雪推出新品豬流行性腹瀉（PEDV）單克隆抗體
- Agrisera直播：從抗體選擇到WB全流程優化策略
- MCE中國抗體實驗圖征稿啟示，秀美圖贏AirPods
- 斯達特生物將亮相2025年美國AACR展會，誠邀您蒞臨！
- MCE直播預告：銅死亡的機制探索與醫學應用
- 2024第九屆疫苗中國領導者年會通知
- MCE推出超900種一抗和多種二抗產品，涵蓋熱門靶點
- 丹納赫將收購Abcam以推動生命科學領域研究創新進程
- 睿捷生物新學期新福利，四重優惠限時享
- 佰諾全景科研mIHC病理技術服務年中大促銷火熱來襲
- 西美杰KPL熱銷二抗和底物限時優惠活動已啟動！
- 美國Jackson二抗產品暑期促銷
- PhytoAB推出調節ABA受體PYLs相關蛋白抗體
- 菲恩生物推出抗體等試劑產品五一節三重禮促銷活動
- 2023疫苗創新國際論壇通知
Copyright(C) 1998-2025 生物器材網 電話：021-64166852;13621656896 E-mail：info@bio-equip.com